Search Ontology:
ChEBI

CGP-42112A

Term ID
CHEBI:147302
Synonyms
  • CGP 42112A
  • CGP-42112
  • CGP-42112A
  • CGP42112A
  • N(6)-[[(phenylmethoxy)carbonyl]-L-Arg-]-N(2)-[[(pyridin-3-yl)carbonyl]-L-Tyr-]-L-Lys-L-His-L-Pro-L-Ile-OH
  • N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridin-3-ylcarbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine
  • N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridine-3-carbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine
  • Nalpha-nicotinoyl-Tyr-(Nalpha-Cbz-Arg)-Lys-His-Pro-Ile
Definition
A hexapeptide consisting of L-tyrosine, L-lysine, L-histidine, L-proline and L-isoleucine amino acid residues coupled in sequence and in which the amino group of the L-tyrosyl residue is substituted by a (pyridin-3-ylcarbonyl)nitrilo group and in which the L-lysyl side chain amino group is substituted by a {N2-[(benzyloxy)carbonyl]-L-arginyl}nitrilo group. It is a potent angiotensin II receptor type 2 (AT2 receptor) agonist.
References
  • cas:127060-75-7
  • pubmed:11454929
  • pubmed:12689346
  • pubmed:14615403
  • pubmed:16380464
  • pubmed:21803946
  • pubmed:23201312
  • pubmed:24712284
  • pubmed:24957202
  • pubmed:25014541
  • pubmed:25100281
  • pubmed:25947168
  • pubmed:2775266
  • pubmed:7606467
  • pubmed:9316402
  • reaxys:8184948
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from CGP-42112A
Phenotype where environments contain CGP-42112A
Phenotype modified by environments containing CGP-42112A
Phenotype affecting CGP-42112A
Human Disease Model